• 1. Elemental fluorine Part 13. Gas–liquid thin film microreactors for selective direct fluorination
  Richard D. Chambers,Darren Holling,Robert C. H. Spink,Graham Sandford Lab Chip 2001 1 132
• 2. Enantioselective synthesis of fluorinated branched allylic compounds via Ir-catalyzed allylations of functionalized fluorinated methylene derivatives
  Hongbo Zhang,Jiteng Chen,Xiao-Ming Zhao Org. Biomol. Chem. 2016 14 7183
• 3. Elemental fluorine Part 16. Versatile thin-film gas–liquid multi-channel microreactors for effective scale-out
  Richard D. Chambers,Mark A. Fox,Darren Holling,Takashi Nakano,Takashi Okazoe,Graham Sandford Lab Chip 2005 5 191
• 4. Mn(iii)-mediated reactions of 2-isocyanobiaryl with 1,3-dicarbonyl compounds: efficient synthesis of 6-alkylated and 6-monofluoro-alkylated phenanthridines
  Jia-Jia Cao,Xiang Wang,Shun-Yi Wang,Shun-Jun Ji Chem. Commun. 2014 50 12892

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Keto acids and derivatives Beta-keto acids and derivatives
• Pharmaceutical and Biochemical Products Medicinal Building Blocks Fluorine containing Building Blocks

Ethyl 2-fluoroacetoacetate (CAS No. 1522-41-4): A Key Intermediate in Modern Pharmaceutical Synthesis

Ethyl 2-fluoroacetoacetate, identified by its Chemical Abstracts Service number CAS No. 1522-41-4, is a versatile and highly valuable compound in the realm of organic synthesis and pharmaceutical development. Its molecular structure, featuring a fluoro-substituted acetoacetate moiety, imparts unique reactivity and functional properties that make it indispensable in the synthesis of fine chemicals and biologically active molecules.

The compound is primarily recognized for its role as an intermediate in the preparation of various pharmacologically relevant molecules. Its ethyl ester group enhances solubility and stability, making it a preferred choice for synthetic chemists working on complex drug candidates. The presence of the fluorine atom at the α-position relative to the carboxyl groups introduces a level of electronic and steric modulation that is critical for fine-tuning the biological activity of derived compounds.

In recent years, Ethyl 2-fluoroacetoacetate has garnered significant attention in the context of developing novel therapeutic agents. One particularly noteworthy application lies in its use as a precursor for small-molecule inhibitors targeting enzyme-catalyzed reactions. These enzymes often play pivotal roles in metabolic pathways associated with diseases such as cancer, inflammation, and neurological disorders. By leveraging the reactivity of Ethyl 2-fluoroacetoacetate, researchers have been able to design molecules that selectively modulate enzyme activity, thereby offering potential therapeutic benefits.

The fluorine atom in Ethyl 2-fluoroacetoacetate exerts a profound influence on the electronic properties of adjacent functional groups. This phenomenon is particularly exploited in medicinal chemistry, where fluorine substitution can enhance binding affinity to biological targets, improve metabolic stability, and prolong drug half-life. Recent studies have demonstrated that derivatives of Ethyl 2-fluoroacetoacetate can serve as scaffolds for generating potent and selective kinase inhibitors, which are increasingly recognized as key players in oncology therapy.

Moreover, the compound's utility extends beyond pharmaceutical applications. It serves as a crucial building block in agrochemical research, where modified acetoacetate derivatives are being explored for their potential as herbicides and fungicides. The fluoro-substituent contributes to enhanced bioavailability and resistance profiles, making these compounds attractive for sustainable agricultural practices.

The synthesis of Ethyl 2-fluoroacetoacetate typically involves fluorinated acetoacetate esters or ketones through esterification or condensation reactions under controlled conditions. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have further refined its production process, ensuring high yields and purity levels required for industrial-scale applications.

Recent advancements in computational chemistry have also highlighted Ethyl 2-fluoroacetoacetate as a promising candidate for virtual screening initiatives. Molecular modeling studies indicate that its structural features align well with binding pockets of various therapeutic targets, suggesting its potential as a lead compound or scaffold for further derivatization. This approach has accelerated the discovery pipeline for new drug candidates by enabling rapid evaluation of large libraries of compounds.

In conclusion, Ethyl 2-fluoroacetoacetate (CAS No. 1522-41-4) represents a cornerstone intermediate in modern synthetic chemistry. Its unique structural attributes and reactivity profile have positioned it as a critical component in the development of innovative pharmaceuticals and agrochemicals. As research continues to uncover new applications and synthetic strategies involving this compound, its significance in advancing chemical biology and drug discovery is poised to grow even further.

• 180287-02-9(2-Fluoro-3-oxopentanoic Acid Methyl Ester)
• 76435-44-4(ethyl 2-fluoro-3-oxohexanoate)
• 650602-38-3(Butanoic acid, 2-fluoro-3-oxo-, pentyl ester)
• 392-64-3(Butanoic acid,2,4-difluoro-3-oxo-, methyl ester)
• 894423-79-1(Butanoic acid,2-fluoro-2-methyl-3-oxo-, 2-fluoroethyl ester)
• 122795-13-5(Butanoic acid,2-fluoro-2-methyl-3-oxo-, ethyl ester)
• 80171-29-5(methyl 2-fluoro-3-oxobutanoate)
• 2266-48-0(Ethyl 2,2-difluoro-3-oxobutanoate)
• 759-67-1(Ethyl 2-fluoro-3-oxopentanoate)
• 196202-02-5(Pentanoic acid,2,4-difluoro-3-oxo-, methyl ester)